VanEck Associates’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-109,388
| Closed | -$5.63M | – | 1413 |
|
|
2022
Q2 | $5.63M | Sell |
109,388
-19,618
| -15% | -$1.01M | 0.01% | 439 |
|
|
2022
Q1 | $9.5M | Buy |
129,006
+10,980
| +9% | +$809K | 0.02% | 370 |
|
|
2021
Q4 | $16.9M | Buy |
118,026
+1,101
| +0.9% | +$158K | 0.04% | 280 |
|
|
2021
Q3 | $24.2M | Sell |
116,925
-19,149
| -14% | -$3.97M | 0.06% | 229 |
|
|
2021
Q2 | $28.9M | Sell |
136,074
-31,524
| -19% | -$6.69M | 0.07% | 216 |
|
|
2021
Q1 | $30.4M | Buy |
167,598
+57,294
| +52% | +$10.4M | 0.08% | 181 |
|
|
2020
Q4 | $12.3M | Buy |
110,304
+34,889
| +46% | +$3.89M | 0.04% | 277 |
|
|
2020
Q3 | $8.17M | Buy |
+75,415
| New | +$8.17M | 0.03% | 288 |
|